← Leaderboards
Peter D Katsikis
Mcp Hahnemann University
$10,160,335
Attributed
$10,160,335
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$10,160,335 · 7
By mechanism
R01$8,042,259 · 4
R33$1,328,927 · 1
R21$414,149 · 1
R56$375,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Mcp Hahnemann University
Same institution · by research overlap
- Elizabeth P. Blankenhorn$2,073,547
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsApoptosisCellsMediatingLeadCytotoxic T LymphocyteLeukocyte Activation /TransformationIn VitroCessation Of LifePropertyExhibitsImmunityStagingCytokineCd8b1 GenePlayCytotoxicIn VivoAffectInfectionT-LymphocytePublic Health Medicine (Field)ResponseCytotoxicity
Grant awards (28)
Phosphorothioate Oligonucleotides as Microbicides against HIV Transmission$442,778
R33 · FY2014 · AI · contact PI
Phosphorothioate Oligonucleotides as Microbicides against HIV Transmission$422,021
R33 · FY2013 · AI · contact PI
Phosphorothioate Oligonucleotides as Microbicides against HIV Transmission$464,128
R33 · FY2012 · AI · contact PI
Phosphorothioate Oligonucleotides as Microbicides against HIV Transmission$206,426
R21 · FY2011 · AI · contact PI
In vitro stimulation of HIV specific CD8+ T cells$353,636
R01 · FY2010 · AI · contact PI
Phosphorothioate Oligonucleotides as Microbicides against HIV Transmission$207,723
R21 · FY2010 · AI · contact PI
In vitro stimulation of HIV specific CD8+ T cells$357,207
R01 · FY2009 · AI · contact PI
Dendritic cell regulation of CD8+ T cell responses$348,812
R01 · FY2009 · AI · contact PI
IL-15 treatment of SIV-infected non-human primates$417,764
R01 · FY2008 · AI · contact PI
In vitro stimulation of HIV specific CD8+ T cells$357,207
R01 · FY2008 · AI · contact PI
Dendritic cell regulation of CD8+ T cell responses$348,812
R01 · FY2008 · AI · contact PI
IL-15 treatment of SIV-infected non-human primates$555,363
R01 · FY2007 · AI · contact PI
In vitro stimulation of HIV specific CD8+ T cells$364,125
R01 · FY2007 · AI · contact PI
Dendritic cell regulation of CD8+ T cell responses$355,567
R01 · FY2007 · AI · contact PI
IL-15 treatment od SIV-infected non-human primates$572,380
R01 · FY2006 · AI · contact PI
Dendritic cell regulation of CD8+ T cell responses$366,188
R01 · FY2006 · AI · contact PI
In vitro stimulation of HIV specific CD8+ T cells$359,375
R01 · FY2006 · AI · contact PI
IL-15 treatment of SIV-infected non-human primates$554,682
R01 · FY2005 · AI
In vitro stimulation of HIV specific CD8+ T cells$375,000
R56 · FY2005 · AI
Enhancing HIV-specific CD8+ T cells with IL-15.$339,750
R01 · FY2005 · AI
Dendritic cell regulation of CD8+ T cell responses$318,750
R01 · FY2005 · AI
Enhancing HIV-specific CD8+ T cells with IL-15.$339,750
R01 · FY2004 · AI
Enhancing HIV-specific CD8+ T cells with IL-15.$339,750
R01 · FY2003 · AI
IN VITRO STIMULATION OF HIV SPECIFIC CD8+ T CELLS$275,137
R01 · FY2003 · AI
Enhancing HIV-specific CD8+ T cells with IL-15.$339,750
R01 · FY2002 · AI
IN VITRO STIMULATION OF HIV SPECIFIC CD8+ T CELLS$267,124
R01 · FY2002 · AI
IN VITRO STIMULATION OF HIV SPECIFIC CD8+ T CELLS$259,342
R01 · FY2001 · AI
IN VITRO STIMULATION OF HIV SPECIFIC CD8+ T CELLS$251,788
R01 · FY2000 · AI